Spacelite – SLC -another interesting asset backed token built on the Master Protocol – by Judith – BizDev at the Mastercoin Foundation

Dear Masterminds,
 Mastercoin is an amazing  foundation that is being adopted and implemented by innovators all over the globe. As time goes by, this fact is just getting more and more reinforced.
The Master Protocol became the platform for asset-backed tokens. reward-backed tokens,reputation-backed tokens. Idea-backed tokens and many more.
Would you beleive  that the Master Protocol can support projects that expertise in Life Science R&D?
Now is is clear that Innovation and thinking out of the box has no limits and we are happy to be the fertile ground for that.
Today I would like to introduce you to the Spacelite project – Life Science R&D
SLC- Spacelite  is an asset backed token, each SLC is backed by 100 grams of SpaceLite, a highly medicinal potassium-oxygen based alkaline electrolyte mineral for human consumption.
SpaceLite is a Life Sciences company that continues to R&D natural life extension nutrients & technologies. It produces a  unique formula that is simply added to water, enhancing your training ability by giving  a boost of natural elements, which increase  muscle development and reducs lactic acid in conjunction with a series of other health benefits.
For more details visit: http://www.spacelite.info
Info from http://www.armedforces-int.com/suppliers/spacelite-military-operation-training-supplement.html
The strength of a  the Master Protocol lies in its ecosystem and usage.

Great things are happening to the Master Protocol

Point of contact for companies and organizations who want to issue a token

 (Judith Jakubovics) Judith (-at-) Mastercoin.org and on Skype: Judith.Jakubovics

Spacelite – SLC -another interesting asset backed token built on the Master Protocol – by Judith – BizDev at the Mastercoin Foundation

One thought on “Spacelite – SLC -another interesting asset backed token built on the Master Protocol – by Judith – BizDev at the Mastercoin Foundation

Comments are closed.